Mulberry (Morus alba L.) ethanol extract attenuates lipid metabolic disturbance and adipokine imbalance in high-fat fed rats
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: An imbalanced adipokine profile in obesity increases the susceptibility to obesity-related cardiometabolic alterations, including type 2 diabetes, hypertension, dyslipidemia, and non-alcoholic fatty liver disease. The mulberry plant has been reported to have health benefits, such as hypolipidemic and hepatoprotective effects. This study examined the effects of a mulberry (Morus alba L.) fruit ethanol extract (MBEE) on dyslipidemia, liver steatosis, and adipokine imbalance in response to a high-fat diet. MATERIALS/METHODS: Male Sprague-Dawley rats were assigned to one of 4 groups containing 6 rats each and fed either a control diet (CON), a high-fat diet (HFD), or a high-fat diet with MBEE of 150 mg/kg/day (LMB) or 300 mg/kg/day (HMB). The triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) activities were measured spectrophotometrically. The leptin, adiponectin, and plasminogen activator inhibitor-1 (PAI-1) levels were determined by an enzyme-linked immunosorbent assay. RESULTS: The plasma TG levels were similar in the 4 groups. Plasma cholesterol and low-density lipoprotein cholesterol (LDL-C) levels and TC/HDL-C ratio increased in the HFD group compared with the CON group, whereas those values decreased in the LMB group (P < 0.05), indicating that MBEE had a plasma lipid-lowering effect. HDL-C decreased in the HFD group, but MBEE did not affect the HDL-C level. The HFD rats significantly increased hepatic TG and cholesterol levels and plasma ALT and AST activities compared to the CON group. The hepatic TG level and ALT and AST activities were reduced markedly by the MBEE treatment. The HFD group showed a higher PAI-1 level, whereas MBEE treatment, especially in the HMB group, significantly reduced leptin level, and leptin/adiponectin and PAI-1/adiponectin ratios. These findings suggest that MBEE altered the imbalance between the pro- and anti-inflammatory adipokines to a more anti-inflammatory state. CONCLUSIONS: MBEE could protect against abnormal lipid metabolism and hepatic steatosis induced by a high-fat diet, lowering plasma cholesterol, LDL-C and TC/HDL-C, and hepatic TG. These findings are associated with the regulating effect of MBEE on the leptin/adiponectin and PAI-1/adiponectin ratios.
Abstract
BACKGROUND/OBJECTIVES: An imbalanced adipokine profile in obesity increases the susceptibility to obesity-related cardiometabolic alterations, including type 2 diabetes, hypertension, dyslipidemia, and non-alcoholic fatty liver disease. The mulberry plant has been reported to have health benefits, such as hypolipidemic and hepatoprotective effects. This study examined the effects of a mulberry (Morus alba L.) fruit ethanol extract (MBEE) on dyslipidemia, liver steatosis, and adipokine imbalance in response to a high-fat diet. MATERIALS/METHODS: Male Sprague-Dawley rats were assigned to one of 4 groups containing 6 rats each and fed either a control diet (CON), a high-fat diet (HFD), or a high-fat diet with MBEE of 150 mg/kg/day (LMB) or 300 mg/kg/day (HMB). The triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) activities were measured spectrophotometrically. The leptin, adiponectin, and plasminogen activator inhibitor-1 (PAI-1) levels were determined by an enzyme-linked immunosorbent assay. RESULTS: The plasma TG levels were similar in the 4 groups. Plasma cholesterol and low-density lipoprotein cholesterol (LDL-C) levels and TC/HDL-C ratio increased in the HFD group compared with the CON group, whereas those values decreased in the LMB group (P < 0.05), indicating that MBEE had a plasma lipid-lowering effect. HDL-C decreased in the HFD group, but MBEE did not affect the HDL-C level. The HFD rats significantly increased hepatic TG and cholesterol levels and plasma ALT and AST activities compared to the CON group. The hepatic TG level and ALT and AST activities were reduced markedly by the MBEE treatment. The HFD group showed a higher PAI-1 level, whereas MBEE treatment, especially in the HMB group, significantly reduced leptin level, and leptin/adiponectin and PAI-1/adiponectin ratios. These findings suggest that MBEE altered the imbalance between the pro- and anti-inflammatory adipokines to a more anti-inflammatory state. CONCLUSIONS: MBEE could protect against abnormal lipid metabolism and hepatic steatosis induced by a high-fat diet, lowering plasma cholesterol, LDL-C and TC/HDL-C, and hepatic TG. These findings are associated with the regulating effect of MBEE on the leptin/adiponectin and PAI-1/adiponectin ratios.
참고문헌 (48)
- Kishida K, "Clinical importance of assessment of type 2 diabetes mellitus with visceral obesity. A Japanese perspective", Curr Diabetes Rev, 8, pp.84~91 (2012)
- Calabrò P, "The role of adiposity as a determinant of an inflammatory milieu", J Cardiovasc Med(Hagerstown), 9, pp.450~460 (2008)
- Golia E, "Adipose tissue and vascular inflammation in coronary artery disease", World J Cardiol, 6, pp.539~554 (2014)
- Fasshauer M, "Adipokines in health and disease", Trends Pharmacol Sci, 36, pp.461~470 (2015)
- Ouchi N, "Adipokines in inflammation and metabolic disease", Nat Rev Immunol, 11, pp.85~97 (2011)
- Maresca F, "Adipokines, vascular wall, and cardiovascular disease : a focused overview of the role of adipokines in the pathophysiology of cardiovascular disease", Angiology, 66, pp.8~24 (2015)
- Adolph TE, "Adipokines and non-alcoholic fatty liver disease : multiple interactions", Int J Mol Sci, 18, pp.1649~1663 (2017)
- Ge F, "Insulin-and leptin-regulated fatty acid uptake plays a key causal role in hepatic steatosis in mice with intact leptin signaling but not in ob", ob or db, Am J Physiol Gastrointest Liver Physiol, pp.2010, 299[DOI]
- Yanai H, "Beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression : mechanisms and perspectives", Int J Mol Sci, 20, pp.1190~1214 (2019)
- López-Jaramillo P, "The role of leptin", adiponectin ratio in metabolic syndrome and diabetes, 2014, pp.18, 37~45
- Kotani K, "Leptin : adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes : relationship of the index to carotid intima-media thickness", Diabetologia, 48, pp.2684~2686 (2005)
- López-Velázquez JA, "The prevalence of nonalcoholic fatty liver disease in the Americas", Ann Hepatol, 13, pp.166~178 (2014)
- Bradbury MW, "Lipid metabolism in hepatic steatosis", Clin Liver Dis, 8, pp.639~671 (2004)
- Heilbronn L, "Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus", Int J Obes Relat Metab Disord, 28(Suppl 4), pp.S12~S21 (2004)
- Shklyaev S, "Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats", Proc Natl Acad Sci U S A, 100, pp.14217~14222 (2003)
- Yamauchi T, "Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase", Nat Med, 8, pp.1288~1295 (2002)
- Ikejima K, "Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals", Hepatology, 34, pp.288~297 (2001)
- Zhang H, "Effect of mulberry fruit (Morus alba L.) consumption and health outcomes: a mini-review", Antioxidants, 7, pp.69~81 (2018)
- Ahanger MR, "Reaction of mulberry germplasm to frost damage in Kashmir", Res J Agric Sci, 4, pp.180~184 (2013)
- Tang CC, "Hepatoprotective effect of mulberry water extracts on ethanol-induced liver injury via anti-inflammation and inhibition of lipogenesis in C57BL", 6J mice, 2013, pp.62, 786~796
- Friedewald WT, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge", Clin Chem, 18, pp.499~502 (1972)
- Folch J, "A simple method for the isolation and purification of total lipides from animal tissues", J Biol Chem, 226, pp.497~509 (1957)
- Jung UJ, "Obesity and its metabolic implications : the Role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and non-alcoholic fatty liver disease", Int J Mol Sci, 15, pp.6184~6223 (2014)
- Abdul Kadir NA, "Protective effects of Tamarillo(Cyphomandra betacea)extract against high fat diet induced obesity in Sprague-Dawley rats", J Obes, 2015, pp.846041~ (2015)
- Yang X, "Hypolipidemic and antioxidant effects of mulberry (Morus alba L.) fruit in hyperlipidaemia rats", Food Chem Toxicol, 48, pp.2374~2379 (2010)
- Song H, "Mulberry ethanol extract attenuates hepatic steatosis and insulin resistance in high-fat diet-fed mice", Nutr Res, 36, pp.710~718 (2016)
- 김현복, "Anti-obesity Effect of Mulberry Anthocyanins in C57BL", 6J Mice, 2021, pp.29(5), 317~327[DOI]
- Woods SC, "A controlled high-fat diet induces an obese syndrome in rats", J Nutr, 133, pp.1081~1087 (2003)
- Saleh J, "Regulation of plasma fatty acid metabolism", Clin Chim Acta, 286, pp.163~180 (1999)
- Marsh JB, "Lipoprotein metabolism in obesity and diabetes : insights from stable isotope kinetic studies in humans", Nutr Rev, 61, pp.363~375 (2003)
- Aguilera CM, "Alterations in plasma and tissue lipids associated with obesity and metabolic syndrome", Clin Sci(Lond), 114, pp.183~193 (2008)
- Hutley L, "Fat as an endocrine organ : relationship to the metabolic syndrome", Am J Med Sci, 330, pp.280~289 (2005)
- Goldstein BJ, "Adiponectin : a novel adipokine linking adipocytes and vascular function", J Clin Endocrinol Metab, 89, pp.2563~2568 (2004)
- Juhan-Vague I, "Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk", J Thromb Haemost, 1, pp.1575~1579 (2003)
- Meiliana A, "The relationship of proinflammatory and antiinflammatory adipokines in the development of metabolic syndrome in centrally obese men", Indones Biomed J, 2, pp.118~125 (2010)
- Masquio DC, "The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents", Br J Nutr, 113, pp.1920~1930 (2015)
- Mikami K, "Leptin", adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population, 2020, pp.126, 154927~
- Adejumo EN, "Leptin : adiponectin ratio discriminated the risk of metabolic syndrome better than adiponectin and leptin in Southwest Nigeria", Diabetes Metab Syndr, 13, pp.1845~1849 (2019)
- Friedman SL, "Mechanisms of NAFLD development and therapeutic strategies", Nat Med, 24, pp.908~922 (2018)
- Packard CJ, "Causes and consequences of hypertriglyceridemia", Front Endocrinol(Lausanne), 11, pp.252~266 (2020)
- Alves-Bezerra M, "Triglyceride metabolism in the liver", Compr Physiol, 8, pp.1~8 (2017)
- Farrell NJ, "Black elderberry extract attenuates inflammation and metabolic dysfunction in diet-induced obese mice", Br J Nutr, 114, pp.1123~1131 (2015)
- Marques V, "Adiponectin, leptin, and IGF-1 are useful diagnostic and stratification biomarkers of NAFLD", Front Med(Lausanne), 8, pp.683250~ (2021)
- Achari AE, "Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction", Int J Mol Sci, 18, pp.1321~1337 (2017)
- Bril F, "Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease", Hepatology, 65, pp.1132~1144 (2017)
- Chang JJ, "Mulberry anthocyanins inhibit oleic acid induced lipid accumulation by reduction of lipogenesis and promotion of hepatic lipid clearance", J Agric Food Chem, 61, pp.6069~6076 (2013)
- Jiang Y, "Effects of the ethanol extract of black mulberry (Morus nigra L.) fruit on experimental atherosclerosis in rats", J Ethnopharmacol, 200, pp.228~235 (2017)
- Chen CC, "Mulberry extract inhibits the development of atherosclerosis in cholesterol-fed rabbits", Food Chem, 91, pp.601~607 (2005)